decreased circulating free fatty acid level_Apoa2<tm1Bres>/Apoa2<tm1Bres>

http://metadb.riken.jp/0002702I129S4SvJaeApoa2tm1BresApoa2tm1BresApoa2tm1Bres

decreased circulating free fatty acid level_Apoa2<tm1Bres>/Apoa2<tm1Bres>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• apolipoprotein A-II
  http://metadb.riken.jp/db/mgi_rdf/MGI:88050

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apoa2<tm1Bres>/Apoa2<tm1Bres>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Apoa2<tm1Bres>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S4/SvJae

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating free fatty acid level
  http://purl.obolibrary.org/obo/MP_0002702

文献

http://purl.org/net/cito/citesAsAuthority

• W. Weng, et.al., Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility., Proceedings of the National Academy of Sciences of the United States of America, 1996, 93
  http://rdf.ncbi.nlm.nih.gov/pubmed/8962133